• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

DOPAMINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

IFNG CASP3 STREPTOCOCCUS PNEUMONIAE FOXP3 CELL DIFFERENTIATION HELICOBACTER PYLORI IL17A TH17 CELLS IMMUNE RESPONSE ERBB-2 STAPHYLOCOCCUS AUREUS IL23A PSEUDOMONAS AERUGINOSA INFLAMMATION CTLA4 CANCER TNF AGING DIABETES MELLITUS PORPHYROMONAS GINGIVALIS ANGIOGENESIS CLOSTRIDIUM DIFFICILE CELL DEATH ESCHERICHIA COLI RECEPTOR REMICADE INSULIN ALZHEIMER'S DISEASE CD4 LISTERIA MONOCYTOGENES TP53 SOD1 CANDIDA ALBICANS RHEUMATOID ARTHRITIS NEURODEGENERATIVE DISORDERS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE PARKINSON DISEASE DOXORUBICIN CELL PROLIFERATION AUTOPHAGY METFORMIN APOPTOTIC PROCESS BREAST CANCER CELL DIVISION IL6

© 2019 Biovista Vizit All Rights Reserved.